N/A N=40 Effect of Neuromuscular Block and Arterial PCO2 on Surgical Rating Scale (SRS), Following Reversal With Sugammadex
Prostate Cancer · Renal Cancer
Primary: Surgical Rating Scale — 4.86; 4.75 units on a scale — p=0.59
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=81 A Study to Evaluate the Efficacy and Safety of CT-P27 in an Influenza Challenge Model
Influenza A
Primary: Viral Load AUC (Day 1 to Day 9) by Nasopharyngeal Swab Quantitative PCR — 6.474; 6.974; 11.639 Days*Eq log10 TCID50/mL
N/A N=185 Thrombelastography Based Dosing of Enoxaparin
Thromboembolic Complications
Primary: Development of Deep Vein Thrombosis (DVT) — 6; 5 Participants
N/A N=326 Engaging Patients With Mental Disorders From the ED in Outpatient Care
Mental Disorder
Primary: Number of Participants Attending at Least One Outpatient Visit — 85; 70 Participants
Phase 2 N=13 Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy
Osteosarcoma · Nephrotoxicity · Ototoxicity
Primary: Change in Urinary Biomarkers of Acute Kidney Injury (AKI) Between Pre-Treatment (Baseline), After CISplatin (C) Treatments, and After HDTMX Treatments — 1.7; 1.7; 2.1…
Phase 3 N=509 A Study to Evaluate Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to DMARDs
Rheumatoid Arthritis
Primary: Percentage of Participants With an American College of Rheumatology 20% (ACR20) C-Reactive Protein (CRP) Response at Week 12 — 30.7; 57.7; 74.5; 83.5 Percentage of…
N/A N=500 Mobile Technology for Improved Family Planning
Contraception · Post-abortion Family Planning · mHealth
Primary: Use of a Effective Contraceptive Method at Four-months Post-abortion — 135; 101 participants
N/A N=15 Continuous Glucose Monitoring (CGM) With a Low Carbohydrate Diet to Reduce Weight in Patients With Pre-Diabetes
Pre-diabetes
Primary: Participant Satisfaction With Continuous Glucose Monitoring (CGM) — 10; 4; 1; 0 participants
Phase 2 N=24 Zonisamide in Addition to E-CPT-C for Veterans With PTSD and Comorbid Alcohol Dependence
Alcohol Dependence · Post-Traumatic Stress Disorder (PTSD)
Primary: Number of Drinking Days — 46.87; 51.00; 7.44; 17.33 days
Phase 4 N=43 Effect of Gender and HIV Infection on Zidovudine and Lamivudine Pharmacokinetics
HIV
Primary: ZDV-TP Drug Levels Compared Between HIV Negative and HIV Infected Subject — 33.89; 29.7 pmol/10^6 cells
N/A N=11 Hypoglycemia (Low Blood Sugar) and the Heart
Hypoglycemia · Type 2 Diabetes
Primary: Number of Participants With Hypoglycemia (Blood Sugar Level <70 mg/dl — 11 Participants
Phase 4 N=822 Genetically Informed Smoking Cessation Trial
Smoking Cessation
Primary: 7-day Point Prevalence Quit Rate — 55; 70; 24 Participants
N/A N=50 Pilot Behavioral Support Intervention After Bariatric Surgery
Obesity
Primary: Difference in Mean Health-Related Quality of Life (HRQoL) Scores Related to Physical Function, Energy Level and General Health. — 11.4; 4.6 score on a scale
Phase 4 N=17 Ketamine Infusion for Adolescent Depression and Anxiety
Major Depressive Disorder · Anxiety Disorder
Primary: Montgomery-Asberg Depression Rating Scale Score 1 Day After Infusion — 15.44; 24.13 units on a scale
Phase 3 N=455 ERADICATE Hp2 - Treating Helicobacter Pylori With RHB-105 Compared to Active Comparator
Helicobacter Pylori Infection · Dyspepsia
Primary: Number of Participants With Eradication of H. Pylori — 191; 131 Participants — p=0.0001